Peer Review History
| Original SubmissionJune 30, 2020 |
|---|
|
PONE-D-20-20150 Experiences managing pregnant hospital staff members using an active management policy – A qualitative study PLOS ONE Dear Dr. Backhausen, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please find the reviewer comments below. The reviewers have requested additional clarification on several points, particularly regarding the level of detail presented in the methods, in order to ensure that the study is reproducible by another researcher (PLOS ONE publication criterion #3). The reviewers have also provided suggestions for the framing of the discussions section, as well as other major and minor revision requests. Please submit your revised manuscript by Dec 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Hanna Landenmark Associate Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a copy of the topic/interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously. 3. Thank you for stating the following financial disclosure. Please amend your Financial disclosure statement to declare sources of funding, or state that the authors received no specific funding: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." At this time, please address the following queries:
Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. The introduction section needs to clearly define what is meant by 'job adjustments' and 'active management policy' to lay the foundation for the manuscript. 2. The aim of the study as it reads is to obtain manager perception of sickness absence while in the introduction there is more reference to perspectives of pregnant staff. Statements such as studies 'show that job adjustments are only made for half of the pregnant employees who state a need for it. This could indicate lack of focus on the working environment among pregnant women' makes it confusing if pregnant staff are not seeking their entitlements or if the managers are denying it. 3. The methods section needs to be clarified further as in one instance it is said that there were 5 FGDs but there were 19 participants in total. Is it possible that some of the FGDs had 4 or less participants? why were there 5 FGDs in the first place? and were there any differences in who participated in which FGD (this is mentioned in limitations but need to be explained upfront in the methods section itself). 4. Given that the FGDs were held a year after the seminar participation of the managers, it is possible that all their views are after learning the correct approaches and can be a major limitation of the study. 5. The chosen themes are not self-explanatory and do not seem corroborating with the sub-themes. Themes are usually more crisp and punchier than the sub-themes. The articulation of themes need to be from the manager perspective - as it seems it is unclear if they are manager perspectives of staff perspectives. 6. There can be a better choice of quotes to align with the themes - it is important to mention if the sub-themes were coming from many participants or just one participant in one FGD. 7. Given that the study takes an inductive perspective, the themes need to be brought together to develop a coherent theory and this is not clear in the discussion. 8. Reflexivity and positionality of the authors need to be made more explicit in the methods section. Reviewer #2: I congratulate the authors to an interesting paper. I have some comments. Triangulation mostly describes involving using multiple sources of data in an investigation. The authors describe that they used triangulation meaning that different health care professionals/researchers were analyzing the data. However, this study could be referred to a mixed method study if the qualitative study was planned from the project’s start to complement the RCT. But, the published study protocol does not describe the qualitative study, eg population, data collection or the qualitative analysis. I want more information about the intervention ie. the education of the leaders, which can increase the value of the study’ and make it reproducible. Reviewer #3: ABSTRACT It is unclear from reading the abstract by itself where this study took place. An additional sentence clarifying location and sample population would be useful. DATA AVAILABILITY Per my reading of the PLOS ONE guidelines, my understanding is that the Methods section should contain information regarding how to access the data used in this study - even if the full dataset is not publicly available. PREDICTIONS Even though this study is largely qualitative in nature, a set of predictions would be a good addition. DISCUSSION Much of this paper hinges on the idea of unnecessary sick leave (at least from the manager perspective) and how to prevent it. I would've liked to see a deeper discussion of pregnancy itself and how variable symptom prevalence/severity, incidence of medical complications, and real occupational threats factor in to the dynamic between pregnant individuals and the workplace. How does one determine if sick leave is necessary or not? I think this is especially critical, given the observation that medical practitioners appear to have a very different threshold for workplace risk than managers. I'd also like to know more regarding actual exposure risk in these work environments and to what degree women are right to be worried about possible infection (especially considering certain aspects of immune function are down-regulated during pregnancy, producing increased risk of viral infections). How many of these managers oversaw acute health settings (e.g. ICU) versus more chronic long-term care (e.g. med-surg), and does this factor in to employee anxiety regarding sick leave? Lines 171-175 give some idea of the dataset makeup, but little is said regarding possible differences between types of healthcare in the results/discussion. LINE EDITS line 72-73: The wording here is confusing. Do pregnant women themselves lack awareness, or do their managers/co-workers lack awareness? I assume you mean the latter, but restructuring this sentence would easily clear this up. line 238: Unnecessary use of "e.g." line 264: Labeling all concerns from friends and family as "myths" is probably too strong a statement. The way it is currently written does not clarify whether this was the chosen wording of the managers or of the authors. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Experiences managing pregnant hospital staff members using an active management policy – A qualitative study PONE-D-20-20150R1 Dear Ms. Backhausen, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sathyanarayanan Doraiswamy, MD, DHealth Guest Editor PLOS ONE Additional Editor Comments (optional): The authors have done a very good job in factoring in the reviewer comments. This updated version is rich in content and has a nice flow to it. Well done! In the abstract you say 'Four thematic themes' under Results - you may want to edit it to just say 'themes'. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-20150R1 Experiences managing pregnant hospital staff members using an active management policy – A qualitative study Dear Dr. Backhausen: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sathyanarayanan Doraiswamy Guest Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .